John F DiPersio, MD
Disclosures: Equity Ownership-Magenta Therapeutics|Equity Ownership-WUGEN|Consulting Fee-Amphivena Therapeutics|Consulting Fee-Celgene|Salary-Incyte|Consulting Fee-Karyopharm Therapeutics|Consulting Fee-RiverVest Venture Partners|Consulting Fee-Tioma Therapeutics|Consulting Fee-Zymeworks|Advisory Committee-Cellworks Group, Inc.|Advisory Committee-RiverVest Venture Partners|Advisory Committee-Zymeworks|Contracted Research-Amphivena Therapeutics|Contracted Research-Novimmune|Speaking Fee-BioLineRx, Ltd|Speaking Fee-Dava Oncology|Speaking Fee-Macrogenics, Inc.|Speaking Fee-NeoImmune Tech, Inc|Speaking Fee-MJH LifeEvents
No Bio Available.